心脏移植新分配时代透析率及后续死亡率升高
该研究分析2009年11月至2020年2月接受单器官心脏移植的既往未透析成人,发现UNOS分配政策改变后,术后需透析的急性肾损伤(AKI-D)总体患病率从10.2%升至13.5%,术前ECMO使用率从0.58%升至5.6%,且AKI-D患者5年和10年生存率显著降低。
要点
- 新分配政策实施后,心脏移植术后AKI-D患病率由10.2%升至13.5%。
- 术前ECMO使用率在新政策时代显著增加(5.6% vs 0.58%)。
- 术前ECMO、IABP、呼吸机及较长缺血时间是AKI-D的独立危险因素。
核心结论
- 心脏移植术后发生AKI-D的患者短期和长期结局显著更差。
- 术前ECMO、术前呼吸机支持和较长缺血时间是AKI-D的危险因素,且其 prevalence 自分配政策改变后增加。
研究设计与样本
- 回顾性队列研究,纳入2009年11月至2020年2月接受单器官心脏移植的既往未透析成人,按是否发生AKI-D分层。
- 共纳入20 698例患者。
- 比较UNOS分配政策改变前后的两个时代(era 1和era 2)。
- 采用多变量logistic回归确定AKI-D危险因素,倾向性评分匹配比较AKI-D发生率,Kaplan-Meier分析比较生存率。
主要发现
- era 2静脉-动脉ECMO使用率显著高于era 1(5.6% vs 0.58%;P < .01)。
- era 2 AKI-D总体患病率高于era 1(13.5% vs 10.2%;P < .01)。
- 术前ECMO、主动脉内球囊反搏、呼吸机和较长缺血时间被确定为AKI-D的独立危险因素。
- AKI-D患者5年和10年生存率显著降低。
- AKI-D患者在era 2与较近期的era 1之间无短期生存差异。
关键数值与推荐
- era 2与era 1静脉-动脉ECMO使用率:5.6% vs 0.58%(P < .01)。
- era 2与era 1 AKI-D总体患病率:13.5% vs 10.2%(P < .01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2018, a United Network for Organ Sharing (UNOS) policy change increased prioritization of patients bridged with temporary mechanical circulatory support devices, such as venoarterial ECMO, for cardiac transplantation. Considering increased waitlist acuity, we sought to characterize whether this was associated with an increased risk for development of postoperative acute renal failure requiring dialysis (AKI-D) and risk of death after transplantation. METHODS: Dialysis-naive adults receiving single-organ heart transplant between November 2009 and February 2020 were stratified by receipt of AKI-D. Era 1 and era 2 were defined by the periods of UNOS allocation before and after policy change, respectively. Multivariable logistic regression was performed to determine risk factors for AKI-D. Rates of AKI-D were compared by propensity score-matched cohorts. Survival was compared by Kaplan-Meier analysis. RESULTS: A total of 20 698 patients were included. Venoarterial ECMO use significantly increased in era 2 (5.6% vs 0.58%; P < .01). Overall prevalence of AKI-D was greater in era 2 (13.5% vs 10.2%; P < .01). Use of preoperative ECMO, intra-aortic balloon pump, and ventilators and longer ischemia times were identified as independent risk factors for development of AKI-D. Five- and 10-year survival rates were significantly decreased for patients with AKI-D. There was no short-term survival difference of patients with AKI-D between era 2 and the more contemporary era 1. CONCLUSIONS: Patients in whom AKI-D develops after transplantation have significantly worse short- and long-term outcomes. Preoperative use of ECMO, preoperative ventilator support, and longer ischemia times are risk factors for development of AKI-D, and their prevalence has increased since the allocation policy change.
引用
- Shin M, Han JJ, Cohen WG, et al. Higher Rates of Dialysis and Subsequent Mortality in the New Allocation Era for Heart Transplants. Ann Thorac Surg. 2022. PMID: 35926639. doi:10.1016/j.athoracsur.2022.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。